{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T10:44:20Z","timestamp":1784371460858,"version":"3.55.0"},"reference-count":119,"publisher":"Bentham Science Publishers Ltd.","issue":"14","funder":[{"DOI":"10.13039\/501100003069","name":"Secretaria de Investigacion y Posgrado del Instituto Politecnico Nacional","doi-asserted-by":"publisher","award":["SIP-20210050"],"award-info":[{"award-number":["SIP-20210050"]}],"id":[{"id":"10.13039\/501100003069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Parasitic diseases caused by protozoa, such as Chagas disease,\nleishmaniasis, malaria, African trypanosomiasis, amoebiasis, trichomoniasis, and giardiasis,\nare considered serious public health problems in developing countries. Drug resistance\namong parasites justifies the search for new therapeutic drugs, and the identification\nof new targets becomes a valuable approach. In this scenario, the glycolysis pathway,\nwhich converts glucose into pyruvate, plays an important role in the protozoa energy supply,\nand it is therefore considered a promising target. In this pathway, triose phosphate\nisomerase (TIM) plays an essential role in efficient energy production. Furthermore, protozoa\nTIM shows structural differences with human enzyme counterparts, suggesting the\npossibility of obtaining selective inhibitors. Therefore, TIM is considered a valid approach\nto develop new antiprotozoal agents, inhibiting the glycolysis in the parasite.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>In this review, we discuss the drug design strategies, structure-activity relationship,\nand binding modes of outstanding TIM inhibitors against Trypanosoma cruzi,\nTrypanosoma brucei, Plasmodium falciparum, Giardia lamblia, Leishmania mexicana,\nTrichomonas vaginalis, and Entamoeba histolytica.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>TIM inhibitors have mainly shown aromatic systems and symmetrical structure,\nwhere the size and type of heteroatom are important for enzyme inhibition. This inhibition\nis mainly based on the interaction with i) the interfacial region of TIM inducing changes\non the quaternary and tertiary structure or ii) with the TIM catalytic region, the main\npathways that disable the catalytic activity of the enzyme.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Benzothiazole, benzoxazole, benzimidazole, and sulfhydryl derivatives stand\nout as TIM inhibitors. In silico and in vitro studies have demonstrated that the inhibitors\nbind mainly at the TIM dimer interface. In this review, the development of new TIM inhibitors\nas antiprotozoal drugs is demonstrated as an important pharmaceutical strategy\nthat may lead to new therapies for these ancient parasitic diseases.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867328666210913090928","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T07:06:11Z","timestamp":1631775971000},"page":"2504-2529","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Recent Advances in the Development of Triose Phosphate Isomerase\nInhibitors as Antiprotozoal Agents"],"prefix":"10.2174","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9327-9658","authenticated-orcid":true,"given":"Lenci K.","family":"V\u00e1zquez-Jim\u00e9nez","sequence":"first","affiliation":[{"name":"Laboratorio de Biotecnolog\u00eda Farmac\u00e9utica, Centro de Biotecnolog\u00eda Gen\u00f3mica, Instituto Polit\u00e9cnico\nNacional, 88710 Reynosa, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7541-1267","authenticated-orcid":true,"given":"Antonio","family":"Moreno-Herrera","sequence":"additional","affiliation":[{"name":"Laboratorio de Biotecnolog\u00eda Farmac\u00e9utica, Centro de Biotecnolog\u00eda Gen\u00f3mica, Instituto Polit\u00e9cnico\nNacional, 88710 Reynosa, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4059-7361","authenticated-orcid":true,"given":"Alfredo","family":"Ju\u00e1rez-Saldivar","sequence":"additional","affiliation":[{"name":"Laboratorio de Biotecnolog\u00eda Farmac\u00e9utica, Centro de Biotecnolog\u00eda Gen\u00f3mica, Instituto Polit\u00e9cnico\nNacional, 88710 Reynosa, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7512-859X","authenticated-orcid":true,"given":"Alonzo","family":"Gonz\u00e1lez-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Laboratorio de Biotecnolog\u00eda Farmac\u00e9utica, Centro de Biotecnolog\u00eda Gen\u00f3mica, Instituto Polit\u00e9cnico\nNacional, 88710 Reynosa, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyra","family":"Ortiz-P\u00e9rez","sequence":"additional","affiliation":[{"name":"Laboratorio de Biotecnolog\u00eda Farmac\u00e9utica, Centro de Biotecnolog\u00eda Gen\u00f3mica, Instituto Polit\u00e9cnico\nNacional, 88710 Reynosa, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0938-6304","authenticated-orcid":true,"given":"Alma D.","family":"Paz-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Laboratorio de Biotecnolog\u00eda Farmac\u00e9utica, Centro de Biotecnolog\u00eda Gen\u00f3mica, Instituto Polit\u00e9cnico\nNacional, 88710 Reynosa, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0124-531X","authenticated-orcid":true,"given":"Isidro","family":"Palos","sequence":"additional","affiliation":[{"name":"Unidad Acad\u00e9mica Multidisciplinaria Reynosa-Rodhe, Universidad\nAut\u00f3noma de Tamaulipas, 88779 Reynosa, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6924-6541","authenticated-orcid":true,"given":"Esther","family":"Ram\u00edrez-Moreno","sequence":"additional","affiliation":[{"name":"Escuela Nacional de Medicina y Homeopat\u00eda, Instituto Polit\u00e9cnico Nacional, 07320 Ciudad de M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9842-4167","authenticated-orcid":true,"given":"Gildardo","family":"Rivera","sequence":"additional","affiliation":[{"name":"Laboratorio de Biotecnolog\u00eda Farmac\u00e9utica, Centro de Biotecnolog\u00eda Gen\u00f3mica, Instituto Polit\u00e9cnico\nNacional, 88710 Reynosa, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.4103\/0975-7406.142943","volume":"6","author":"Kumar S.","year":"2014","unstructured":"Kumar S.; Ali M.R.; Bawa S.; Mini review on tricyclic compounds as an inhibitor of trypanothione reductase. J Pharm Bioallied Sci 2014,6(4),222-228","journal-title":"J Pharm Bioallied Sci"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/S0074-02762013000100001","volume":"108","author":"Fr&#xED;as L.","year":"2013","unstructured":"Fr&#xED;as L.; Leles D.; Ara&#xFA;jo A.; Studies on protozoa in ancient remains--a review. Mem Inst Oswaldo Cruz 2013,108(1),1-12","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref=3","unstructured":"WHO. Health topics: Infectious diseases. Available from: https:\/\/www.who.int\/topics\/infectious_diseases\/en\/(Accessed February, 2020)"},{"key":"ref=4","year":"2012","unstructured":"WHO.Accelerating Work to Overcome the Global Impact of Neglected Tropical Diseases a Roadmap for Implementation; World Health Organization: 20 Avenue Appia, 1211 Geneva 27, Switzerland2012"},{"key":"ref=5","unstructured":"CDC Centers of Disease Control and PreventionParasites-\tAmerican Trypanosomiasis (also known as Chagas Disease)\tAvailable from:  https:\/\/www.cdc.gov\/parasites\/chagas\/epi. html(Accessed February, 2020)","journal-title":"CDC Centers of Disease Control and PreventionParasites-\tAmerican Trypanosomiasis (also known as Chagas Disease)\tAvailable from:"},{"key":"ref=6","unstructured":"PAHO Pan American Health Organization 2020 Available from:  https:\/\/www.paho.org\/hq\/index.php?option=com_topics","journal-title":"PAHO Pan American Health Organization 2020 Available from:"},{"key":"ref=7","unstructured":"WHO. WHO model prescribing information: drugs used in parasitic diseases, World Health Organization, 1995 , 2nd ed. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/41765"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1056\/NEJM199605023341808","volume":"334","author":"Liu L.X.","year":"1996","unstructured":"Liu L.X.; Weller P.F.; Peter F.; Weller M.D.; Antiparasitic drugs. N Engl J Med 1996,334(18),1178-1184","journal-title":"N Engl J Med"},{"key":"ref=9","first-page":"175","volume":"5","author":"Chatelain E.","year":"2011","unstructured":"Chatelain E.; Ioset J.R.; Drug discovery and development for neglected diseases: the DNDi model. Drug Des Devel Ther 2011,5,175-181","journal-title":"Drug Des Devel Ther"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2174\/1568026024607472","volume":"2","author":"Lakhdar-Ghazal F.","year":"2002","unstructured":"Lakhdar-Ghazal F.; Blonski C.; Willson M.; Michels P.; Perie J.; Glycolysis and proteases as targets for the design of new anti-trypanosome drugs. Curr Top Med Chem 2002,2(5),439-456","journal-title":"Curr Top Med Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nrd1657","volume":"4","author":"Koehn F.E.","year":"2005","unstructured":"Koehn F.E.; Carter G.T.; The evolving role of natural products in drug discovery. Nat Rev Drug Discov 2005,4(3),206-220","journal-title":"Nat Rev Drug Discov"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-94-007-7305-9_2","volume":"74","author":"Smirlis D.","year":"2014","unstructured":"Smirlis D.; Soares M.B.; Selection of molecular targets for drug development against trypanosomatids. Subcell Biochem 2014,74,43-76","journal-title":"Subcell Biochem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3390\/molecules21030368","volume":"21","author":"Ortiz C.","year":"2016","unstructured":"Ortiz C.; Moraca F.; Medeiros A.; Botta M.; Hamilton N.; Comini M.A.; Binding mode and selectivity of steroids towards glucose-6-phosphate dehydrogenase from the pathogen Trypanosoma cruzi. Molecules 2016,21(3),368","journal-title":"Molecules"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1590\/0074-02760170267","volume":"113","author":"Aguilera E.","year":"2018","unstructured":"Aguilera E.; Varela J.; Serna E.; Torres S.; Yaluff G.; Bilbao N.V.; Cerecetto H.; &#xC1;lvarez G.; Gonz&#xE1;lez M.; Looking for combination of benznidazole and Trypanosoma cruzi-triosephosphate isomerase inhibitors for Chagas disease treatment. Mem Inst Oswaldo Cruz 2018,113(3),153-160","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"5403","DOI":"10.2174\/0929867326666190628163633","volume":"27","author":"Cortez-Maya S.","year":"2020","unstructured":"Cortez-Maya S.; Moreno-Herrera A.; Palos I.; Rivera G.; Old antiprotozoal drugs: are they still viable options for parasitic infections or new options for other diseases? Curr Med Chem 2020,27(32),5403-5428","journal-title":"Curr Med Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.biopha.2018.12.058","volume":"111","author":"Carapina da Silva C.","year":"2019","unstructured":"Carapina da Silva C.; Pacheco B.S.; das Neves, R.N.; Di&#xE9; Alves, M.S.; Sena-Lopes, &#xC2;.; Moura, S.; Borsuk, S.; de Pereira, C.M.P. Antiparasitic activity of synthetic curcumin monocarbonyl analogues against Trichomonas vaginalis. Biomed Pharmacother 2019,111,367-377","journal-title":"Biomed Pharmacother"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/S0020-7519(01)00155-2","volume":"31","author":"Opperdoes F.R.","year":"2001","unstructured":"Opperdoes F.R.; Michels P.A.; Enzymes of carbohydrate metabolism as potential drug targets. Int J Parasitol 2001,31(5-6),482-490","journal-title":"Int J Parasitol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"7767","DOI":"10.1074\/jbc.M114.574525","volume":"290","author":"Mantilla B.S.","year":"2015","unstructured":"Mantilla B.S.; Paes L.S.; Pral E.M.F.; Martil D.E.; Thiemann O.H.; Fern&#xE1;ndez-Silva P.; Bastos E.L.; Silber A.M.; Role of \u03941-pyrroline-5-carboxylate dehydrogenase supports mitochondrial metabolism and host-cell invasion of Trypanosoma cruzi. J Biol Chem 2015,290(12),7767-7790","journal-title":"J Biol Chem"},{"key":"ref=19","doi-asserted-by":"publisher","DOI":"10.3390\/scipharm85010005","volume":"85","author":"Setzer M.S.","year":"2017","unstructured":"Setzer M.S.; Byler K.G.; Ogungbe I.V.; Setzer W.N.; Natural Products as New Treatment Options for Trichomoniasis: A Molecular Docking Investigation. Sci Pharm E52017,85(1)","journal-title":"Sci Pharm"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1054\/drup.2000.0177","volume":"4","author":"Verlinde C.L.","year":"2001","unstructured":"Verlinde C.L.; Hannaert V.; Blonski C.; Willson M.; P&#xE9;ri&#xE9; J.J.; Fothergill-Gilmore L.A.; Opperdoes F.R.; Gelb M.H.; Hol W.G.; Michels P.A.; Glycolysis as a target for the design of new anti-trypanosome drugs. Drug Resist Updat 2001,4(1),50-65","journal-title":"Drug Resist Updat"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.molbiopara.2015.12.004","volume":"204","author":"D\u2019Antonio E.L.","year":"2015","unstructured":"D\u2019Antonio E.L.; Deinema M.S.; Kearns S.P.; Frey T.A.; Tanghe S.; Perry K.; Roy T.A.; Gracz H.S.; Rodriguez A.; D\u2019Antonio J.; Structure-based approach to the identification of a novel group of selective glucosamine analogue inhibitors of Trypanosoma cruzi glucokinase. Mol Biochem Parasitol 2015,204(2),64-76","journal-title":"Mol Biochem Parasitol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3109\/14756366.2014.1001755","volume":"30","author":"De Monte C.","year":"2015","unstructured":"De Monte C.; Bizzarri B.; Gidaro M.C.; Carradori S.; Mollica A.; Luisi G.; Granese A.; Alcaro S.; Costa G.; Basilico N.; Parapini S.; Scaltrito M.M.; Masia C.; Sisto F.; Bioactive compounds of Crocus sativus L. and their semi-synthetic derivatives as promising anti-Helicobacter pylori, anti-malarial and anti-leishmanial agents. J Enzyme Inhib Med Chem 2015,30(6),1027-1033","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"5767","DOI":"10.1016\/j.ejmech.2010.09.034","volume":"45","author":"&#xC1;lvarez G.","year":"2010","unstructured":"&#xC1;lvarez G.; Aguirre-L&#xF3;pez B.; Varela J.; Cabrera M.; Merlino A.; L&#xF3;pez G.V.; Lavaggi M.L.; Porcal W.; Di Maio R.; Gonz&#xE1;lez M.; Cerecetto H.; Cabrera N.; P&#xE9;rez-Montfort R.; de G&#xF3;mez-Puyou M.T.; G&#xF3;mez-Puyou A.; Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity. Eur J Med Chem 2010,45(12),5767-5772","journal-title":"Eur J Med Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.1021\/bi982425s","volume":"38","author":"P&#xE9;rez-Montfort R.","year":"1999","unstructured":"P&#xE9;rez-Montfort R.; Garza-Ramos G.; Alc&#xE1;ntara G.H.; Reyes-Vivas H.; Gao X.G.; Maldonado E.; de G&#xF3;mez-Puyou M.T.; G&#xF3;mez-Puyou A.; Derivatization of the interface cysteine of triosephosphate isomerase from Trypanosoma brucei and Trypanosoma cruzi as probe of the interrelationship between the catalytic sites and the dimer interface. Biochemistry 1999,38(13),4114-4120","journal-title":"Biochemistry"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/1074-5521(95)90091-8","volume":"2","author":"G&#xF3;mez-Puyou A.","year":"1995","unstructured":"G&#xF3;mez-Puyou A.; Saavedra-Lira E.; Becker I.; Zubillaga R.A.; Rojo-Dom&#xED;nguez A.; P&#xE9;rez-Montfort R.; Using evolutionary changes to achieve species-specific inhibition of enzyme action--studies with triosephosphate isomerase. Chem Biol 1995,2(12),847-855","journal-title":"Chem Biol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1021\/bi0206560","volume":"42","author":"Zomosa-Signoret V.","year":"2003","unstructured":"Zomosa-Signoret V.; Hern&#xE1;ndez-Alc&#xE1;ntara G.; Reyes-Vivas H.; Mart&#xED;nez-Mart&#xED;nez E.; Garza-Ramos G.; P&#xE9;rez-Montfort R.; Tuena De G&#xF3;mez-Puyou M.; G&#xF3;mez-Puyou A.; Control of the reactivation kinetics of homodimeric triosephosphate isomerase from unfolded monomers. Biochemistry 2003,42(11),3311-3318","journal-title":"Biochemistry"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"15889","DOI":"10.1021\/jacs.8b09378","volume":"140","author":"Liao Q.","year":"2018","unstructured":"Liao Q.; Kulkarni Y.; Sengupta U.; Petrovi\u0107 D.; Mulholland A.J.; van der Kamp M.W.; Strodel B.; Kamerlin S.C.L.; Loop Motion in Triosephosphate Isomerase Is Not a Simple Open and Shut Case. J Am Chem Soc 2018,140(46),15889-15903","journal-title":"J Am Chem Soc"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"14595","DOI":"10.3390\/molecules200814595","volume":"20","author":"Couto M.","year":"2015","unstructured":"Couto M.; S&#xE1;nchez C.; D&#xE1;vila B.; Mach&#xED;n V.; Varela J.; &#xC1;lvarez G.; Cabrera M.; Celano L.; Aguirre-L&#xF3;pez B.; Cabrera N.; de G&#xF3;mez-Puyou M.T.; G&#xF3;mez-Puyou A.; P&#xE9;rez-Montfort R.; Cerecetto H.; Gonz&#xE1;lez M.; 3-H-[1,2]Dithiole as a new anti-Trypanosoma cruzi chemotype: biological and mechanism of action studies. Molecules 2015,20(8),14595-14610","journal-title":"Molecules"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/prot.25299","volume":"85","author":"Olivares-Illana V.","year":"2017","unstructured":"Olivares-Illana V.; Riveros-Rosas H.; Cabrera N.; Tuena de G&#xF3;mez-Puyou M.; P&#xE9;rez-Montfort R.; Costas M.; G&#xF3;mez-Puyou A.; A guide to the effects of a large portion of the residues of triosephosphate isomerase on catalysis, stability, druggability, and human disease. Proteins 2017,85(7),1190-1211","journal-title":"Proteins"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/BF02099950","volume":"24","author":"Michels P.A.","year":"1986","unstructured":"Michels P.A.; Evolutionary aspects of trypanosomes: analysis of genes. J Mol Evol 1986,24(1-2),45-52","journal-title":"J Mol Evol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/0169-4758(93)90168-F","volume":"9","author":"Blum J.J.","year":"1993","unstructured":"Blum J.J.; Intermediary metabolism of Leishmania. Parasitol Today 1993,9(4),118-122","journal-title":"Parasitol Today"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.1007\/s00018-010-0473-9","volume":"67","author":"Wierenga R.K.","year":"2010","unstructured":"Wierenga R.K.; Kapetaniou E.G.; Venkatesan R.; Triosephosphate isomerase: a highly evolved biocatalyst. Cell Mol Life Sci 2010,67(23),3961-3982","journal-title":"Cell Mol Life Sci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1021\/bi0522293","volume":"45","author":"Olivares-Illana V.","year":"2006","unstructured":"Olivares-Illana V.; P&#xE9;rez-Montfort R.; L&#xF3;pez-Calahorra F.; Costas M.; Rodr&#xED;guez-Romero A.; Tuena de G&#xF3;mez-Puyou M.; G&#xF3;mez Puyou A.; Structural differences in triosephosphate isomerase from different species and discovery of a multitrypanosomatid inhibitor. Biochemistry 2006,45(8),2556-2560","journal-title":"Biochemistry"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1006\/jmbi.1998.2094","volume":"283","author":"Maldonado E.","year":"1998","unstructured":"Maldonado E.; Soriano-Garc&#xED;a M.; Moreno A.; Cabrera N.; Garza-Ramos G.; de G&#xF3;mez-Puyou M.; G&#xF3;mez-Puyou A.; Perez-Montfort R.; Differences in the intersubunit contacts in triosephosphate isomerase from two closely related pathogenic trypanosomes. J Mol Biol 1998,283(1),193-203","journal-title":"J Mol Biol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ejmech.2015.06.018","volume":"100","author":"&#xC1;lvarez G.","year":"2015","unstructured":"&#xC1;lvarez G.; Mart&#xED;nez J.; Varela J.; Birriel E.; Cruces E.; Gabay M.; Leal S.M.; Escobar P.; Aguirre-L&#xF3;pez B.; Cabrera N.; Tuena de G&#xF3;mez-Puyou M.; G&#xF3;mez Puyou A.; P&#xE9;rez-Montfort R.; Yaluff G.; Torres S.; Serna E.; Vera de Bilbao N.; Gonz&#xE1;lez M.; Cerecetto H.; Development of bis-thiazoles as inhibitors of triosephosphate isomerase from Trypanosoma cruzi. Identification of new non-mutagenic agents that are active in vivo. Eur J Med Chem 2015,100,246-256","journal-title":"Eur J Med Chem"},{"key":"ref=36","doi-asserted-by":"publisher","DOI":"10.1016\/j.parint.2020.102086","volume":"76","author":"Vique-S&#xE1;nchez J.L.","year":"2020","unstructured":"Vique-S&#xE1;nchez J.L.; Caro-G&#xF3;mez L.A.; Brieba L.G.; Ben&#xED;tez-Cardoza C.G.; Developing a new drug against trichomoniasis, new inhibitory compounds of the protein triosephosphate isomerase. Parasitol Int 2020,76","journal-title":"Parasitol Int"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.bbadis.2009.09.012","volume":"1792","author":"Orosz F.","year":"2009","unstructured":"Orosz F.; Ol&#xE1;h J.; Ov&#xE1;di J.; Triosephosphate isomerase deficiency: new insights into an enigmatic disease. Biochim Biophys Acta 2009,1792(12),1168-1174","journal-title":"Biochim Biophys Acta"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"16828","DOI":"10.1021\/bi982089f","volume":"37","author":"Harris T.K.","year":"1998","unstructured":"Harris T.K.; Cole R.N.; Comer F.I.; Mildvan A.S.; Proton transfer in the mechanism of triosephosphate isomerase. Biochemistry 1998,37(47),16828-16838","journal-title":"Biochemistry"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1021\/bi300195b","volume":"51","author":"Richard J.P.","year":"2012","unstructured":"Richard J.P.; A paradigm for enzyme-catalyzed proton transfer at carbon: triosephosphate isomerase. Biochemistry 2012,51(13),2652-2661","journal-title":"Biochemistry"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1042\/bj1350165","volume":"135","author":"Waley S.G.","year":"1973","unstructured":"Waley S.G.; Refolding of triose phosphate isomerase. Biochem J 1973,135(1),165-172","journal-title":"Biochem J"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1515\/znc-1980-11-1224","volume":"35","author":"Zabori S.","year":"1980","unstructured":"Zabori S.; Rudolph R.; Jaenicke R.; Folding and association of triose phosphate isomerase from rabbit muscle. Z Naturforsch C 1980,35(11-12),999-1004","journal-title":"Z Naturforsch C"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.1046\/j.0014-2956.2001.02452.x","volume":"268","author":"Kursula I.","year":"2001","unstructured":"Kursula I.; Partanen S.; Lambeir A.M.; Antonov D.M.; Augustyns K.; Wierenga R.K.; Structural determinants for ligand binding and catalysis of triosephosphate isomerase. Eur J Biochem 2001,268(19),5189-5196","journal-title":"Eur J Biochem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/(SICI)1097-0134(19991115)37:3<441:AID-PROT11>3.0.CO;2-7","volume":"37","author":"Maes D.","year":"1999","unstructured":"Maes D.; Zeelen J.P.; Thanki N.; Beaucamp N.; &#xC1;lvarez M.; Thi M.H.; Backmann J.; Martial J.A.; Wyns L.; Jaenicke R.; Wierenga R.K.; The crystal structure of triosephosphate isomerase (TIM) from Thermotoga maritima: a comparative thermostability structural analysis of ten different TIM structures. Proteins 1999,37(3),441-453","journal-title":"Proteins"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1107\/S2053230X19001882","volume":"75","author":"Kelp\u0161as V.","year":"2019","unstructured":"Kelp\u0161as V.; Lafumat B.; Blakeley M.P.; Coquelle N.; Oksanen E.; von Wachenfeldt C.; Perdeuteration, large crystal growth and neutron data collection of Leishmania mexicana triose-phosphate isomerase E65Q variant. Acta Crystallogr F Struct Biol Commun 2019,75(Pt 4),260-269","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"100062","DOI":"10.1073\/pnas.96.18.10062","volume":"96","author":"Gao X.G.","year":"1999","unstructured":"Gao X.G.; Maldonado E.; P&#xE9;rez-Montfort R.; Garza-Ramos G.; de G&#xF3;mez-Puyou M.T.; G&#xF3;mez-Puyou A.; Rodr&#xED;guez-Romero A.; Crystal structure of triosephosphate isomerase in hexane. Proc Natl Acad Sci USA 1999,96,100062-100067","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1006\/jmbi.1996.0174","volume":"257","author":"Mainfroid V.","year":"1996","unstructured":"Mainfroid V.; Terpstra P.; Beauregard M.; Fr&#xE8;re J.M.; Mande S.C.; Hol W.G.; Martial J.A.; Goraj K.; Three hTIM mutants that provide new insights on why TIM is a dimer. J Mol Biol 1996,257(2),441-456","journal-title":"J Mol Biol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3109\/14756366.2013.765415","volume":"29","author":"&#xC1;lvarez G.","year":"2014","unstructured":"&#xC1;lvarez G.; Mart&#xED;nez J.; Aguirre-L&#xF3;pez B.; Cabrera N.; P&#xE9;rez-D&#xED;az L.; de G&#xF3;mez-Puyou M.T.; G&#xF3;mez-Puyou A.; P&#xE9;rez-Montfort R.; Garat B.; Merlino A.; Gonz&#xE1;lez M.; Cerecetto H.; New chemotypes as Trypanosoma cruzi triosephosphate isomerase inhibitors: a deeper insight into the mechanism of inhibition. J Enzyme Inhib Med Chem 2014,29(2),198-204","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1432-1033.1992.tb17069.x","volume":"207","author":"Kuntz D.A.","year":"1992","unstructured":"Kuntz D.A.; Osowski R.; Schudok M.; Wierenga R.K.; M&#xFC;ller K.; Kessler H.; Opperdoes F.R.; Inhibition of triosephosphate isomerase from Trypanosoma brucei with cyclic hexapeptides. Eur J Biochem 1992,207(2),441-447","journal-title":"Eur J Biochem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3390\/biom10071050","volume":"10","author":"Enr&#xED;quez-Flores S.","year":"2020","unstructured":"Enr&#xED;quez-Flores S.; Flores-L&#xF3;pez L.A.; Garc&#xED;a-Torres I.; de la Mora-de la Mora I.; Cabrera N.; Guti&#xE9;rrez-Castrell&#xF3;n P.; Mart&#xED;nez-P&#xE9;rez Y.; L&#xF3;pez-Vel&#xE1;zquez G.; Deamidated human triosephosphate isomerase is a promising druggable target. Biomolecules 2020,10(7),1050","journal-title":"Biomolecules"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1432-1033.1997.00348.x","volume":"247","author":"Landa A.","year":"1997","unstructured":"Landa A.; Rojo-Dom&#xED;nguez A.; Jim&#xE9;nez L.; Fern&#xE1;ndez-Velasco D.A.; Sequencing, expression and properties of triosephosphate isomerase from Entamoeba histolytica. Eur J Biochem 1997,247(1),348-355","journal-title":"Eur J Biochem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"25106","DOI":"10.1074\/jbc.M202419200","volume":"277","author":"Maithal K.","year":"2002","unstructured":"Maithal K.; Ravindra G.; Balaram H.; Balaram P.; Inhibition of plasmodium falciparum triose-phosphate isomerase by chemical modification of an interface cysteine. Electrospray ionization mass spectrometric analysis of differential cysteine reactivities. J Biol Chem 2002,277(28),25106-25114","journal-title":"J Biol Chem"},{"key":"ref=52","first-page":"68","volume":"30","author":"Garc&#xED;a-Torres I.","year":"2011","unstructured":"Garc&#xED;a-Torres I.; P&#xE9;rez-Montfort R.; Avances en la identificaci&#xF3;n de blancos terap&#xE9;uticos y el dise&#xF1;o racional de f&#xE1;rmacos contra la enfermedad de chagas. REB 2011,30(2),68-81","journal-title":"REB"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1073\/pnas.91.4.1515","volume":"91","author":"Borchert T.V.","year":"1994","unstructured":"Borchert T.V.; Abagyan R.; Jaenicke R.; Wierenga R.K.; Design, creation, and characterization of a stable, monomeric triosephosphate isomerase. Proc Natl Acad Sci USA 1994,91(4),1515-1518","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/protein\/14.3.149","volume":"14","author":"Saab-Rinc&#xF3;n G.","year":"2001","unstructured":"Saab-Rinc&#xF3;n G.; Ju&#xE1;rez V.R.; Osuna J.; S&#xE1;nchez F.; Sober&#xF3;n X.; Different strategies to recover the activity of monomeric triosephosphate isomerase by directed evolution. Protein Eng 2001,14(3),149-155","journal-title":"Protein Eng"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1046\/j.1432-1327.1998.2530684.x","volume":"253","author":"Garza-Ramos G.","year":"1998","unstructured":"Garza-Ramos G.; Cabrera N.; Saavedra-Lira E.; Tuena de G&#xF3;mez-Puyou M.; Ostoa-Saloma P.; P&#xE9;rez-Montfort R.; G&#xF3;mez-Puyou A.; Sulfhydryl reagent susceptibility in proteins with high sequence similarity--triosephosphate isomerase from Trypanosoma brucei, Trypanosoma cruzi and Leishmania mexicana. Eur J Biochem 1998,253(3),684-691","journal-title":"Eur J Biochem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/protein\/12.3.243","volume":"12","author":"Williams J.C.","year":"1999","unstructured":"Williams J.C.; Zeelen J.P.; Neubauer G.; Vriend G.; Backmann J.; Michels P.A.; Lambeir A.M.; Wierenga R.K.; Structural and mutagenesis studies of leishmania triosephosphate isomerase: a point mutation can convert a mesophilic enzyme into a superstable enzyme without losing catalytic power. Protein Eng 1999,12(3),243-250","journal-title":"Protein Eng"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/0022-2836(91)90368-G","volume":"220","author":"Wierenga R.K.","year":"1991","unstructured":"Wierenga R.K.; Noble M.E.; Vriend G.; Nauche S.; Hol W.G.; Refined 1.83 A structure of trypanosomal triosephosphate isomerase crystallized in the presence of 2.4 M-ammonium sulphate. A comparison with the structure of the trypanosomal triosephosphate isomerase-glycerol-3-phosphate complex. J Mol Biol 1991,220(4),995-1015","journal-title":"J Mol Biol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.jmb.2004.06.056","volume":"341","author":"T&#xE9;llez-Valencia A.","year":"2004","unstructured":"T&#xE9;llez-Valencia A.; Olivares-Illana V.; Hern&#xE1;ndez-Santoyo A.; P&#xE9;rez-Montfort R.; Costas M.; Rodr&#xED;guez-Romero A.; L&#xF3;pez-Calahorra F.; Tuena De G&#xF3;mez-Puyou M.; G&#xF3;mez-Puyou A.; Inactivation of triosephosphate isomerase from Trypanosoma cruzi by an agent that perturbs its dimer interface. J Mol Biol 2004,341(5),1355-1365","journal-title":"J Mol Biol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S0969-2126(97)00230-X","volume":"5","author":"Velanker S.S.","year":"1997","unstructured":"Velanker S.S.; Ray S.S.; Gokhale R.S.; Suma S.; Balaram H.; Balaram P.; Murthy M.R.N.; Triosephosphate isomerase from Plasmodium falciparum: the crystal structure provides insights into antimalarial drug design. Structure 1997,5(6),751-761","journal-title":"Structure"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2174\/1568026024607454","volume":"2","author":"Perez-Montfort R.","year":"2002","unstructured":"Perez-Montfort R.; de Gomez-Puyou M.T.; Gomez-Puyou A.; The interfaces of oligomeric proteins as targets for drug design against enzymes from parasites. Curr Top Med Chem 2002,2(5),457-470","journal-title":"Curr Top Med Chem"},{"key":"ref=61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000001","volume":"1","author":"Olivares-Illana V.","year":"2007","unstructured":"Olivares-Illana V.; Rodr&#xED;guez-Romero A.; Becker I.; Berzunza M.; Garc&#xED;a J.; P&#xE9;rez-Montfort R.; Cabrera N.; L&#xF3;pez-Calahorra F.; de G&#xF3;mez-Puyou M.T.; G&#xF3;mez-Puyou A.; Perturbation of the dimer interface of triosephosphate isomerase and its effect on Trypanosoma cruzi. PLoS Negl Trop Dis 2007,1(1)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1016\/j.bmcl.2004.04.013","volume":"14","author":"Espinoza-Fonseca L.M.","year":"2004","unstructured":"Espinoza-Fonseca L.M.; Trujillo-Ferrara J.G.; Exploring the possible binding sites at the interface of triosephosphate isomerase dimer as a potential target for anti-tripanosomal drug design. Bioorg Med Chem Lett 2004,14(12),3151-3154","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.bbrc.2005.01.043","volume":"328","author":"Espinoza-Fonseca L.M.","year":"2005","unstructured":"Espinoza-Fonseca L.M.; Trujillo-Ferrara J.G.; Structural considerations for the rational design of selective anti-trypanosomal agents: the role of the aromatic clusters at the interface of triosephosphate isomerase dimer. Biochem Biophys Res Commun 2005,328(4),922-928","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"6288","DOI":"10.1016\/j.bmcl.2006.09.029","volume":"16","author":"Espinoza-Fonseca L.M.","year":"2006","unstructured":"Espinoza-Fonseca L.M.; Trujillo-Ferrara J.G.; Toward a rational design of selective multi-trypanosomatid inhibitors: a computational docking study. Bioorg Med Chem Lett 2006,16(24),6288-6292","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00436-007-0803-5","volume":"102","author":"Cort&#xE9;s-Figueroa A.A.","year":"2008","unstructured":"Cort&#xE9;s-Figueroa A.A.; P&#xE9;rez-Torres A.; Salaiza N.; Cabrera N.; Escalona-Monta&#xF1;o A.; Rond&#xE1;n A.; Aguirre-Garc&#xED;a M.; G&#xF3;mez-Puyou A.; P&#xE9;rez-Montfort R.; Becker I.; A monoclonal antibody that inhibits Trypanosoma cruzi growth in vitro and its reaction with intracellular triosephosphate isomerase. Parasitol Res 2008,102(4),635-643","journal-title":"Parasitol Res"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0014-5793(01)02606-0","volume":"501","author":"Singh S.K.","year":"2001","unstructured":"Singh S.K.; Maithal K.; Balaram H.; Balaram P.; Synthetic peptides as inactivators of multimeric enzymes: inhibition of Plasmodium falciparum triosephosphate isomerase by interface peptides. FEBS Lett 2001,501(1),19-23","journal-title":"FEBS Lett"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1517\/13543784.2014.922952","volume":"23","author":"Bahia M.T.","year":"2014","unstructured":"Bahia M.T.; Diniz, Lde.F.; Mosqueira, V.C. Therapeutical approaches under investigation for treatment of Chagas disease. Expert Opin Investig Drugs 2014,23(9),1225-1237","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"5936","DOI":"10.1016\/j.bmcl.2009.08.055","volume":"19","author":"Gayosso-De-Lucio J.","year":"2009","unstructured":"Gayosso-De-Lucio J.; Torres-Valencia M.; Rojo-Dom&#xED;nguez A.; N&#xE1;jera-Pe&#xF1;a H.; Aguirre-L&#xF3;pez B.; Salas-Pacheco J.; Avitia-Dom&#xED;nguez C.; T&#xE9;llez-Valencia A.; Selective inactivation of triosephosphate isomerase from Trypanosoma cruzi by brevifolin carboxylate derivatives isolated from Geranium bellum Rose. Bioorg Med Chem Lett 2009,19(20),5936-5939","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3390\/ph3040810","volume":"3","author":"Cerecetto H.","year":"2010","unstructured":"Cerecetto H.; Gonz&#xE1;lez M.; Synthetic medicinal chemistry in Chagas\u2019 disease: Compounds at the final stage of &#x201C;Hit-to-Lead&#x201D; phase. Pharmaceuticals (Basel) 2010,3(4),810-838","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1517\/13543776.2011.565334","volume":"21","author":"Gonz&#xE1;lez M.","year":"2011","unstructured":"Gonz&#xE1;lez M.; Cerecetto H.; Novel compounds to combat trypanosomatid infections: a medicinal chemical perspective. Expert Opin Ther Pat 2011,21(5),699-715","journal-title":"Expert Opin Ther Pat"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3109\/14756366.2012.700928","volume":"28","author":"&#xC1;lvarez G.","year":"2013","unstructured":"&#xC1;lvarez G.; Aguirre-L&#xF3;pez B.; Cabrera N.; Marins E.B.; Tinoco L.; Batthy&#xE1;ny C.I.; de G&#xF3;mez-Puyou M.T.; Puyou A.G.; P&#xE9;rez-Montfort R.; Cerecetto H.; Gonz&#xE1;lez M.; 1,2,4-thiadiazol-5(4H)-ones: a new class of selective inhibitors of Trypanosoma cruzi triosephosphate isomerase. Study of the mechanism of inhibition. J Enzyme Inhib Med Chem 2013,28(5),981-989","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jmgm.2015.02.002","volume":"58","author":"Minini L.","year":"2015","unstructured":"Minini L.; &#xC1;lvarez G.; Gonz&#xE1;lez M.; Cerecetto H.; Merlino A.; Molecular docking and molecular dynamics simulation studies of Trypanosoma cruzi triosephosphate isomerase inhibitors. Insights into the inhibition mechanism and selectivity. J Mol Graph Model 2015,58,40-49","journal-title":"J Mol Graph Model"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/S0006-291X(02)00796-9","volume":"295","author":"T&#xE9;llez-Valencia A.","year":"2002","unstructured":"T&#xE9;llez-Valencia A.; Avila-R&#xED;os S.; P&#xE9;rez-Montfort R.; Rodr&#xED;guez-Romero A.; Tuena de G&#xF3;mez-Puyou M.; L&#xF3;pez-Calahorra F.; G&#xF3;mez-Puyou A.; Highly specific inactivation of triosephosphate isomerase from Trypanosoma cruzi. Biochem Biophys Res Commun 2002,295(4),958-963","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1128\/AAC.03814-14","volume":"59","author":"&#xC1;lvarez G.","year":"2015","unstructured":"&#xC1;lvarez G.; Varela J.; Cruces E.; Fern&#xE1;ndez M.; Gabay M.; Leal S.M.; Escobar P.; Sanabria L.; Serna E.; Torres S.; Figueredo Thiel S.J.; Yaluff G.; Vera de Bilbao N.I.; Cerecetto H.; Gonz&#xE1;lez M.; Identification of a new amide-containing thiazole as a drug candidate for treatment of Chagas\u2019 disease. Antimicrob Agents Chemother 2015,59(3),1398-1404","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1002\/cmdc.201500385","volume":"11","author":"Aguilera E.","year":"2016","unstructured":"Aguilera E.; Varela J.; Birriel E.; Serna E.; Torres S.; Yaluff G.; de Bilbao N.V.; Aguirre-L&#xF3;pez B.; Cabrera N.; D&#xED;az Mazariegos S.; de G&#xF3;mez-Puyou M.T.; G&#xF3;mez-Puyou A.; P&#xE9;rez-Montfort R.; Minini L.; Merlino A.; Cerecetto H.; Gonz&#xE1;lez M.; Alvarez G.; Potent and selective inhibitors of Trypanosoma cruzi triosephosphate isomerase with concomitant inhibition of cruzipain: inhibition of parasite growth through multitarget activity. ChemMedChem 2016,11(12),1328-1338","journal-title":"ChemMedChem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.3390\/molecules23102457","volume":"23","author":"Luo B.","year":"2018","unstructured":"Luo B.; Li D.; Zhang A.L.; Gao J.M.; Synthesis, antifungal activities and molecular docking studies of benzoxazole and benzothiazole derivatives. Molecules 2018,23(10),2457","journal-title":"Molecules"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"6723","DOI":"10.3892\/mmr.2018.8719","volume":"17","author":"Cho K.A.","year":"2018","unstructured":"Cho K.A.; Park M.; Kim Y.H.; Choo H.P.; Lee K.H.; Benzoxazole derivatives suppress lipopolysaccharide-induced mast cell activation. Mol Med Rep 2018,17(5),6723-6730","journal-title":"Mol Med Rep"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1080\/1062936X.2019.1684357","volume":"30","author":"Kapil S.","year":"2019","unstructured":"Kapil S.; Singh P.K.; Kashyap A.; Silakari O.; Structure based designing of benzimidazole\/benzoxazole derivatives as anti-leishmanial agents. SAR QSAR Environ Res 2019,30(12),919-933","journal-title":"SAR QSAR Environ Res"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1007\/s00044-012-0264-y","volume":"22","author":"Flores-Sandoval C.A.","year":"2013","unstructured":"Flores-Sandoval C.A.; Cuevas-Hern&#xE1;ndez R.I.; Correa-Basurto J.; Beltr&#xE1;n-Conde H.I.; Padilla-Mart&#xED;nez I.I.; Farf&#xE1;n-Garc&#xED;a J.N.; Nogueda-Torres B.; Trujillo-Ferrara J.G.; Synthesis and theoretic calculations of benzoxazoles and docking studies of their interactions with triosephosphate isomerase. Med Chem Res 2013,22,2768-2777","journal-title":"Med Chem Res"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1016\/j.bmcl.2015.08.018","volume":"26","author":"Vel&#xE1;zquez-L&#xF3;pez J.M.","year":"2016","unstructured":"Vel&#xE1;zquez-L&#xF3;pez J.M.; Hern&#xE1;ndez-Campos A.; Y&#xE9;pez-Mulia L.; T&#xE9;llez-Valencia A.; Flores-Carrillo P.; Nieto-Meneses R.; Castillo R.; Synthesis and trypanocidal activity of novel benzimidazole derivatives. Bioorg Med Chem Lett 2016,26(17),4377-4381","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jmgm.2011.06.009","volume":"30","author":"Romo-Mancillas A.","year":"2011","unstructured":"Romo-Mancillas A.; T&#xE9;llez-Valencia A.; Y&#xE9;pez-Mulia L.; Hern&#xE1;ndez-Luis F.; Hern&#xE1;ndez-Campos A.; Castillo R.; The design and inhibitory profile of new benzimidazole derivatives against triosephosphate isomerase from Trypanosoma cruzi: a problem of residue motility. J Mol Graph Model 2011,30,90-99","journal-title":"J Mol Graph Model"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1002\/minf.201100109","volume":"30","author":"Kurkcuoglu Z.","year":"2011","unstructured":"Kurkcuoglu Z.; Ural G.; Demet Akten E.; Doruker P.; Blind dockings of benzothiazoles to multiple receptor conformations of triosephosphate isomerase from Trypanosoma cruzi and Human. Mol Inform 2011,30(11-12),986-995","journal-title":"Mol Inform"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.bpj.2015.06.031","volume":"109","author":"Kurkcuoglu Z.","year":"2015","unstructured":"Kurkcuoglu Z.; Findik D.; Akten E.D.; Doruker P.; How an inhibitor bound to subunit interface alters triosephosphate isomerase dynamics. Biophys J 2015,109(6),1169-1178","journal-title":"Biophys J"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00044-015-1475-9","volume":"25","author":"Cuevas-Hern&#xE1;ndez R.I.","year":"2016","unstructured":"Cuevas-Hern&#xE1;ndez R.I.; Correa-Basurto J.; Flores-Sandoval C.A.; Padilla-Mart&#xED;nez I.I.; Nogueda-Torres B.; Villa-Tanaca M.L.; Tamay-Cach F.; Nolasco-Fidencio J.J.; Trujillo-Ferrara J.G.; Fluorine-containing benzothiazole as a novel trypanocidal agent: Design, in silico study, synthesis and activity evaluation. Med Chem Res 2016,25,211-224","journal-title":"Med Chem Res"},{"key":"ref=85","first-page":"509","volume":"17","author":"Kawase M.","year":"2003","unstructured":"Kawase M.; Tanaka T.; Sohara Y.; Tani S.; Sakagami H.; Hauer H.; Chatterjee S.S.; Structural requirements of hydroxylated coumarins for in vitro anti-Helicobacter pylori activity. In Vivo 2003,17(5),509-512","journal-title":"In Vivo"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1016\/j.bmcl.2017.04.091","volume":"27","author":"Khomenko T.M.","year":"2017","unstructured":"Khomenko T.M.; Zarubaev V.V.; Orshanskaya I.R.; Kadyrova R.A.; Sannikova V.A.; Korchagina D.V.; Volcho K.P.; Salakhutdinov N.F.; Anti-influenza activity of monoterpene-containing substituted coumarins. Bioorg Med Chem Lett 2017,27(13),2920-2925","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.3390\/cancers12071959","volume":"12","author":"K&#xFC;peli Akkol E.","year":"2020","unstructured":"K&#xFC;peli Akkol E.; Gen&#xE7; Y.; Karpuz B.; Sobarzo-S&#xE1;nchez E.; Capasso R.; Coumarins and coumarin-related compounds in pharmacotherapy of cancer. Cancers (Basel) 2020,12(7),1959","journal-title":"Cancers (Basel)"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/cbdd.13420","volume":"93","author":"Coelho G.S.","year":"2019","unstructured":"Coelho G.S.; Andrade J.S.; Xavier V.F.; Sales Junior P.A.; Rodrigues de Araujo B.C.; Fonseca K.D.S.; Caetano M.S.; Murta S.M.F.; Vieira P.M.; Carneiro C.M.; Taylor J.G.; Design, synthesis, molecular modelling, and in vitro evaluation of tricyclic coumarins against Trypanosoma cruzi. Chem Biol Drug Des 2019,93(3),337-350","journal-title":"Chem Biol Drug Des"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.3390\/molecules14041513","volume":"14","author":"Ogungbe I.V.","year":"2009","unstructured":"Ogungbe I.V.; Setzer W.N.; Comparative molecular docking of antitrypanosomal natural products into multiple Trypanosoma brucei drug targets. Molecules 2009,14(4),1513-1536","journal-title":"Molecules"},{"key":"ref=90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001727","volume":"6","author":"Setzer W.N.","year":"2012","unstructured":"Setzer W.N.; Ogungbe I.V.; In-silico investigation of antitrypanosomal phytochemicals from Nigerian medicinal plants. PLoS Negl Trop Dis 2012,6(7)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=91","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22122055","volume":"22","author":"V&#xE1;zquez-Raygoza A.","year":"2017","unstructured":"V&#xE1;zquez-Raygoza A.; Cano-Gonz&#xE1;lez L.; Vel&#xE1;zquez-Mart&#xED;nez I.; Trejo-Soto P.J.; Castillo R.; Hern&#xE1;ndez-Campos A.; Hern&#xE1;ndez-Luis F.; Oria-Hern&#xE1;ndez J.; Castillo-Villanueva A.; Avitia-Dom&#xED;nguez C.; Sierra-Campos E.; Valdez-Solana M.; T&#xE9;llez-Valencia A.; Species-specific inactivation of triosephosphate isomerase from Trypanosoma brucei: kinetic and molecular dynamics studies. Molecules 2017,22(12)","journal-title":"Molecules"},{"key":"ref=92","first-page":"411","volume":"36","author":"Sahin D.","year":"2012","unstructured":"Sahin D.; Bayrak H.; Demirbas A.; Demirbas N.; Karaoglu S.A.; Design and synthesis of new 1,2,4-triazole derivatives containing morpholine moiety as antimicrobial agents. Turk J Chem 2012,36,411-426","journal-title":"Turk J Chem"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ejmech.2016.05.024","volume":"120","author":"Doan P.","year":"2016","unstructured":"Doan P.; Karjalainen A.; Chandraseelan J.G.; Sandberg O.; Yli-Harja O.; Rosholm T.; Franzen R.; Candeias N.R.; Kandhavelu M.; Synthesis and biological screening for cytotoxic activity of N-substituted indolines and morpholines. Eur J Med Chem 2016,120,296-303","journal-title":"Eur J Med Chem"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"8934","DOI":"10.1021\/acs.jmedchem.8b01148","volume":"61","author":"Degorce S.L.","year":"2018","unstructured":"Degorce S.L.; Bodnarchuk M.S.; Cumming I.A.; Scott J.S.; Lowering lipophilicity by adding carbon: one-carbon bridges of morpholines and piperazines. J Med Chem 2018,61(19),8934-8943","journal-title":"J Med Chem"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"5833","DOI":"10.1021\/jm700938n","volume":"50","author":"Kuettel S.","year":"2007","unstructured":"Kuettel S.; Zambon A.; Kaiser M.; Brun R.; Scapozza L.; Perozzo R.; Synthesis and evaluation of antiparasitic activities of new 4-[5-(4-phenoxyphenyl)-2H-pyrazol-3-yl]morpholine derivatives. J Med Chem 2007,50(23),5833-5839","journal-title":"J Med Chem"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s00044-016-1739-z","volume":"26","author":"Ibezim A.","year":"2016","unstructured":"Ibezim A.; Nwodo N.J.; Nnaji N.J.N.; Ujam O.T.; Olubiyi O.O.; Mba C.J.; In silico investigation of morpholines as novel class of trypanosomal triosephosphate isomerase inhibitors. Med Chem Res 2016,26,180-189","journal-title":"Med Chem Res"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/prot.1133","volume":"45","author":"Joubert F.","year":"2001","unstructured":"Joubert F.; Neitz A.W.; Louw A.I.; Structure-based inhibitor screening: a family of sulfonated dye inhibitors for malaria parasite triosephosphate isomerase. Proteins 2001,45(2),136-143","journal-title":"Proteins"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cmpb.2015.06.005","volume":"122","author":"Swain S.S.","year":"2015","unstructured":"Swain S.S.; Sahu M.C.; Padhy R.N.; In silico attempt for adduct agent(s) against malaria: Combination of chloroquine with alkaloids of Adhatoda vasica. Comput Methods Programs Biomed 2015,122(1),16-25","journal-title":"Comput Methods Programs Biomed"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.molbiopara.2007.10.013","volume":"157","author":"Enr&#xED;quez-Flores S.","year":"2008","unstructured":"Enr&#xED;quez-Flores S.; Rodriguez-Romero A.; Hernandez-Alcantara G.; De la Mora-De la Mora I.; Gutierrez-Castrellon P.; Carvajal K.; Lopez-Velazquez G.; Reyes-Vivas H.; Species-specific inhibition of Giardia lamblia triosephosphate isomerase by localized perturbation of the homodimer. Mol Biochem Parasitol 2008,157(2),179-186","journal-title":"Mol Biochem Parasitol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1002\/prot.23100","volume":"79","author":"Enr&#xED;quez-Flores S.","year":"2011","unstructured":"Enr&#xED;quez-Flores S.; Rodr&#xED;guez-Romero A.; Hern&#xE1;ndez-Alc&#xE1;ntara G.; Oria-Hern&#xE1;ndez J.; Guti&#xE9;rrez-Castrell&#xF3;n P.; P&#xE9;rez-Hern&#xE1;ndez G.; de la Mora-de la Mora I.; Castillo-Villanueva A.; Garc&#xED;a-Torres I.; M&#xE9;ndez S.T.; G&#xF3;mez-Manzo S.; Torres-Arroyo A.; L&#xF3;pez-Vel&#xE1;zquez G.; Reyes-Vivas H.; Determining the molecular mechanism of inactivation by chemical modification of triosephosphate isomerase from the human parasite Giardia lamblia: a study for antiparasitic drug design. Proteins 2011,79(9),2711-2724","journal-title":"Proteins"},{"key":"ref=101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069031","volume":"8","author":"Hern&#xE1;ndez-Alc&#xE1;ntara G.","year":"2013","unstructured":"Hern&#xE1;ndez-Alc&#xE1;ntara G.; Torres-Larios A.; Enr&#xED;quez-Flores S.; Garc&#xED;a-Torres I.; Castillo-Villanueva A.; M&#xE9;ndez S.T.; de la Mora-de la Mora I.; G&#xF3;mez-Manzo S.; Torres-Arroyo A.; L&#xF3;pez-Vel&#xE1;zquez G.; Reyes-Vivas H.; Oria-Hern&#xE1;ndez J.; Structural and functional perturbation of Giardia lamblia triosephosphate isomerase by modification of a non-catalytic, non-conserved region. PLoS One 2013,8(7)","journal-title":"PLoS One"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.2174\/1568026616666160216154309","volume":"16","author":"Sbaraglini M.L.","year":"2016","unstructured":"Sbaraglini M.L.; Vanrell M.C.; Bellera C.L.; Benaim G.; Carrillo C.; Talevi A.; Romano P.S.; Neglected tropical Protozoan diseases: drug repositioning as a rational option. Curr Top Med Chem 2016,16(19),2201-2222","journal-title":"Curr Top Med Chem"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ejmech.2017.03.063","volume":"132","author":"Lara-Ramirez E.E.","year":"2017","unstructured":"Lara-Ramirez E.E.; L&#xF3;pez-Cedillo J.C.; Nogueda-Torres B.; Kashif M.; Garcia-Perez C.; Bocanegra-Garcia V.; Agusti R.; Uhrig M.L.; Rivera G.; An in vitro and in vivo evaluation of new potential trans-sialidase inhibitors of Trypanosoma cruzi predicted by a computational drug repositioning method. Eur J Med Chem 2017,132,249-261","journal-title":"Eur J Med Chem"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3390\/molecules22061015","volume":"22","author":"Palos I.","year":"2017","unstructured":"Palos I.; Lara-Ramirez E.E.; Lopez-Cedillo J.C.; Garcia-Perez C.; Kashif M.; Bocanegra-Garcia V.; Nogueda-Torres B.; Rivera G.; Repositioning FDA Drugs as Potential Cruzain Inhibitors from Trypanosoma cruzi: Virtual Screening, In Vitro and In Vivo Studies. Molecules 2017,22(6),1015","journal-title":"Molecules"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"8809","DOI":"10.3390\/ijms21228809","volume":"21","author":"Adasme M.F.","year":"2020","unstructured":"Adasme M.F.; Bolz S.N.; Adelmann L.; Salentin S.; Haupt V.J.; Moreno-Rodr&#xED;guez A.; Nogueda-Torres B.; Castillo-Campos V.; Yepez-Mulia L.; De Fuentes-Vicente J.A.; Rivera G.; Schroeder M.; Repositioned drugs for chagas disease unveiled via structure-based drug repositioning. Int J Mol Sci 2020,21(22),8809","journal-title":"Int J Mol Sci"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.3390\/ijms21124270","volume":"21","author":"Ju&#xE1;rez-Saldivar A.","year":"2020","unstructured":"Ju&#xE1;rez-Saldivar A.; Schroeder M.; Salentin S.; Haupt V.J.; Saavedra E.; V&#xE1;zquez C.; Reyes-Espinosa F.; Herrera-Mayorga V.; Villalobos-Rocha J.C.; Garc&#xED;a-P&#xE9;rez C.A.; Campillo N.E.; Rivera G.; Computational Drug Repositioning for Chagas Disease Using Protein-Ligand Interaction Profiling. Int J Mol Sci 2020,21(12),4270","journal-title":"Int J Mol Sci"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"7072","DOI":"10.1128\/AAC.02900-14","volume":"58","author":"Reyes-Vivas H.","year":"2014","unstructured":"Reyes-Vivas H.; de la Mora-de la Mora I.; Castillo-Villanueva A.; Y&#xE9;pez-Mulia L.; Hern&#xE1;ndez-Alc&#xE1;ntara G.; Figueroa-Salazar R.; Garc&#xED;a-Torres I.; G&#xF3;mez-Manzo S.; M&#xE9;ndez S.T.; Vanoye-Carlo A.; Marcial-Quino J.; Torres-Arroyo A.; Oria-Hern&#xE1;ndez J.; Guti&#xE9;rrez-Castrell&#xF3;n P.; Enr&#xED;quez-Flores S.; L&#xF3;pez-Vel&#xE1;zquez G.; Giardial triosephosphate isomerase as possible target of the cytotoxic effect of omeprazole in Giardia lamblia. Antimicrob Agents Chemother 2014,58(12),7072-7082","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"8922","DOI":"10.1038\/s41598-019-45529-w","volume":"9","author":"L&#xF3;pez-Vel&#xE1;zquez G.","year":"2019","unstructured":"L&#xF3;pez-Vel&#xE1;zquez G.; Fern&#xE1;ndez-Lainez C.; de la Mora-de la Mora J.I.; Caudillo de la Portilla D.; Reynoso-Robles R.; Gonz&#xE1;lez-Maciel A.; Ridaura C.; Garc&#xED;a-Torres I.; Guti&#xE9;rrez-Castrell&#xF3;n P.; Olivos-Garc&#xED;a A.; Flores-L&#xF3;pez L.A.; Enr&#xED;quez-Flores S.; On the molecular and cellular effects of omeprazole to further support its effectiveness as an antigiardial drug. Sci Rep 2019,9(1),8922","journal-title":"Sci Rep"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.bbagen.2015.10.021","volume":"1860","author":"Garc&#xED;a-Torres I.","year":"2016","unstructured":"Garc&#xED;a-Torres I.; de la Mora-de la Mora I.; Marcial-Quino J.; G&#xF3;mez-Manzo S.; Vanoye-Carlo A.; Navarrete-V&#xE1;zquez G.; Col&#xED;n-Lozano B.; Guti&#xE9;rrez-Castrell&#xF3;n P.; Sierra-Palacios E.; L&#xF3;pez-Vel&#xE1;zquez G.; Enr&#xED;quez-Flores S.; Proton pump inhibitors drastically modify triosephosphate isomerase from Giardia lamblia at functional and structural levels, providing molecular leads in the design of new antigiardiasic drugs. Biochim Biophys Acta 2016,1860(1 Pt A),97-107","journal-title":"Biochim Biophys Acta"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"7810","DOI":"10.1038\/s41598-017-07612-y","volume":"7","author":"Hern&#xE1;ndez-Ochoa B.","year":"2017","unstructured":"Hern&#xE1;ndez-Ochoa B.; Navarrete-V&#xE1;zquez G.; Nava-Zuazo C.; Castillo-Villanueva A.; M&#xE9;ndez S.T.; Torres-Arroyo A.; G&#xF3;mez-Manzo S.; Marcial-Quino J.; Ponce-Macotela M.; Rufino-Gonz&#xE1;lez Y.; Mart&#xED;nez-Gordillo M.; Palencia-Hern&#xE1;ndez G.; Esturau-Escofet N.; Calderon-Jaimes E.; Oria-Hern&#xE1;ndez J.; Reyes-Vivas H.; Novel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation. Sci Rep 2017,7(1),7810","journal-title":"Sci Rep"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.3390\/molecules25173979","volume":"25","author":"Hern&#xE1;ndez-Ochoa B.","year":"2020","unstructured":"Hern&#xE1;ndez-Ochoa B.; G&#xF3;mez-Manzo S.; S&#xE1;nchez-Carrillo A.; Marcial-Quino J.; Rocha-Ram&#xED;rez L.M.; Santos-Segura A.; Ram&#xED;rez-Nava E.J.; Arreguin-Espinosa R.; Cuevas-Cruz M.; M&#xE9;ndez-Tenorio A.; Calder&#xF3;n-Jaimes E.; Enhanced Antigiardial Effect of Omeprazole Analog Benzimidazole Compounds. Molecules 2020,25(17),3979","journal-title":"Molecules"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"41","DOI":"10.18773\/austprescr.2015.015","volume":"38","author":"Crowley P.","year":"2015","unstructured":"Crowley P.; Long-term drug treatment of patients with alcohol dependence. Aust Prescr 2015,38(2),41-43","journal-title":"Aust Prescr"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1128\/AAC.42.6.1488","volume":"42","author":"Nash T.","year":"1998","unstructured":"Nash T.; Rice W.G.; Efficacies of zinc-finger-active drugs against Giardia lamblia. Antimicrob Agents Chemother 1998,42(6),1488-1492","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"10502","DOI":"10.1074\/jbc.M114.553123","volume":"289","author":"Galkin A.","year":"2014","unstructured":"Galkin A.; Kulakova L.; Lim K.; Chen C.Z.; Zheng W.; Turko I.V.; Herzberg O.; Structural basis for inactivation of Giardia lamblia carbamate kinase by disulfiram. J Biol Chem 2014,289(15),10502-10509","journal-title":"J Biol Chem"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ijpddr.2017.11.003","volume":"7","author":"Castillo-Villanueva A.","year":"2017","unstructured":"Castillo-Villanueva A.; Rufino-Gonz&#xE1;lez Y.; M&#xE9;ndez S.T.; Torres-Arroyo A.; Ponce-Macotela M.; Mart&#xED;nez-Gordillo M.N.; Reyes-Vivas H.; Oria-Hern&#xE1;ndez J.; Disulfiram as a novel inactivator of Giardia lamblia triosephosphate isomerase with antigiardial potential. Int J Parasitol Drugs Drug Resist 2017,7(3),425-432","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"5943","DOI":"10.3390\/ijms22115943","volume":"22","author":"Ju&#xE1;rez-Saldivar A.","year":"2021","unstructured":"Ju&#xE1;rez-Saldivar A.; Barbosa-Cabrera E.; Lara-Ram&#xED;rez E.E.; Paz-Gonz&#xE1;lez A.D.; Mart&#xED;nez-V&#xE1;zquez A.V.; Bocanegra-Garc&#xED;a V.; Palos I.; Campillo N.E.; Rivera G.; Virtual Screening of FDA-Approved Drugs against Triose Phosphate Isomerase from Entamoeba histolytica and Giardia lamblia Identifies Inhibitors of Their Trophozoite Growth Phase. Int J Mol Sci 2021,22(11),5943","journal-title":"Int J Mol Sci"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0022-2836(02)00809-4","volume":"322","author":"Rodr&#xED;guez-Romero A.","year":"2002","unstructured":"Rodr&#xED;guez-Romero A.; Hern&#xE1;ndez-Santoyo A.; del Pozo Yauner L.; Kornhauser A.; Fern&#xE1;ndez-Velasco D.A.; Structure and inactivation of triosephosphate isomerase from Entamoeba histolytica. J Mol Biol 2002,322(4),669-675","journal-title":"J Mol Biol"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/07315724.2002.10719202","volume":"21","author":"Olivares J.L.","year":"2002","unstructured":"Olivares J.L.; Fern&#xE1;ndez R.; Fleta J.; Ruiz M.Y.; Clavel A.; Vitamin B12 and folic acid in children with intestinal parasitic infection. J Am Coll Nutr 2002,21(2),109-113","journal-title":"J Am Coll Nutr"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"986","DOI":"10.4269\/ajtmh.2006.74.986","volume":"74","author":"Mulenga M.","year":"2006","unstructured":"Mulenga M.; Malunga P.; Bennett S.; Thuma P.; Shulman C.; Fielding K.; Greenwood B.; Folic acid treatment of Zambian children with moderate to severe malaria anemia. Am J Trop Med Hyg 2006,74(6),986-990","journal-title":"Am J Trop Med Hyg"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867328666210913090928","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/196394\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867328666210913090928","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T05:15:10Z","timestamp":1657170910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/196394\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":119,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867328666210913090928","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-03-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}